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Abstract
Arterial tortuosity syndrome (ATS) is a recessively inherited connective tissue disorder, mainly characterized by tortuosity
and aneurysm formation of the major arteries. ATS is caused by loss-of-function mutations in SLC2A10, encoding the
facilitative glucose transporter GLUT10. Former studies implicated GLUT10 in the transport of dehydroascorbic acid, the
oxidized form of ascorbic acid (AA). Mouse models carrying homozygous Slc2a10 missense mutations did not recapitulate
the human phenotype. Since mice, in contrast to humans, are able to intracellularly synthesize AA, we generated a novel
ATS mouse model, deficient for Slc2a10 as well as Gulo, which encodes for L-gulonolactone oxidase, an enzyme catalyzing
the final step in AA biosynthesis in mouse. Gulo;Slc2a10 double knock-out mice showed mild phenotypic anomalies, which
were absent in single knock-out controls. While Gulo;Slc2a10 double knock-out mice did not fully phenocopy human ATS,
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histological and immunocytochemical analysis revealed compromised extracellular matrix formation. Transforming growth
factor beta signaling remained unaltered, while mitochondrial function was compromised in smooth muscle cells derived
from Gulo;Slc2a10 double knock-out mice. Altogether, our data add evidence that ATS is an ascorbate compartmentalization
disorder, but additional factors underlying the observed phenotype in humans remain to be determined.
Introduction
Arterial tortuosity syndrome (ATS,MIM#208050) is a rare autoso-
mal recessive connective tissue disorder, characterized by severe
patterning defects in blood vessel development. The main fea-
tures of the disease include elongation, tortuosity and steno-
sis of the large and middle-sized arteries, with an increased
risk for aneurysm formation and ischemic events (1–3). Patients
may present with additional connective tissue-related features,
such as cutis laxa, diaphragmatic hernias, joint laxity, distinctive
craniofacial malformations and a marfanoid habitus. Finally,
corneal thinning causing pellucid corneas and keratoconus was
recently described (2,4). The disease has shown to be variable
in terms of severity, ranging from early mortality to mild man-
ifestations in adulthood (1,2,5,6). Arterial histopathology shows
disorganization and fragmentation of the elastic fibers (1,7–10).
Cultured fibroblasts of ATS patients showed disorganization of
the actin cytoskeleton and multiple extracellular matrix (ECM)
components, including fibronectin, fibrillin, type 3 and type 5
collagen and decorin (11,12).
ATS is caused by loss-of-function mutations in the SLC2A10
gene, encoding the GLUT10 protein (3). GLUT10 belongs
to the GLUT family of facilitative transporters, consisting
of 14 transmembrane proteins, enabling the transport of
monosaccharides, polyols and other small carbon compounds
across the membranes of eukaryotic cells (13). GLUT members
show specific functionalities, but some functional redundancy
has been observed. Recent evidence identified GLUT10 as a
transporter of dehydroascorbic acid (DHA), the oxidized form
of ascorbic acid (AA), but its subcellular localization remains
enigmatic and may change upon physiological states. GLUT10
has been shown to reside in mitochondria (14), the nuclear
envelope (3) and/or the endoplasmic reticulum (ER) (15–17).
It remains to be solved how defective DHA transport results
in a vasculopathy related to Loeys-Dietz (18) orMarfan syndrome
(19,20), respectively, caused by perturbed transforming growth
factor beta (TGFβ) pathway signaling or altered ECM proteins.
In the absence of relevant vascular patient material, several
ATS disease models have been developed. Slc2a10 knockdown in
a morpholino-based zebrafish model showed abnormal vascu-
lar patterning and mitochondrial respiration (21). Two knock-in
mouse models, either carrying a homozygous likely pathogenic
G128E or S150Fmissense substitution in Slc2a10 (22,23),were pre-
viously phenotyped by two different research groups. While no
ATS-related abnormalities could be discerned in either mutant
by one of both groups at 3 months of age (23), the other group
found elastic fiber proliferation in older homozygous G128E
mutant mice only (22). It is unclear whether this is related to
the elastic fiber fragmentation seen in the vascular wall of ATS
patients.Recent follow-up studies in thismousemodel indicated
altered redox homeostasis and mitochondrial dysfunction as
pathogenicmechanisms underlying ATS (24), similar to observa-
tions in the morpholino-based zebrafish knockdown model (21)
and in ATS knockdown cell lines (rat A10, mouse 3T3-L1) (14).
Altered redox homeostasis contributes to the pathogenesis in
other aneurysm-related diseases (25).
A growing evidence that GLUT10 functions as an AA trans-
porter has led to the hypothesis that the innate AA synthesizing
capacity of mice could rescue the phenotype. Therefore, we
characterized a novel mouse model for ATS, with gene disrup-
tions of both Slc2a10, the causal gene for ATS, and Gulo, which
encodes L-gulonolactone, the enzyme catalyzing the last step in
AA biosynthesis in mouse.
Results
Generation of the Slc2a10;Gulo double knock-out mouse
model
Wedeveloped a novelmousemodel for ATS in amixed 129/SvEv-
C57BL/6 genetic background by crossing constitutive knock-out
lines for Gulo and Slc2a10, both harboring a selection cassette
replacing multiple exons (Supplementary Material, Fig. S1A).
To take into account any possible effect of a variable genetic
background on the acquired data, all studies were performed on
littermates from the F2 generation (Supplementary Material, Fig.
S1B). RT-qPCR-based expression analysis, using primers target-
ing the sequence replaced by the selection cassette, confirmed
the absence of wild-type (WT) Slc2a10 RNA in the skin and
aorta obtained from Slc2a10 −/− animals (DKO and Slc2a10 KO)
(Fig. 1). Double knock-out mice (DKO—Gulo tm1mae/tm1mae;Slc2a10
−/−) were born with expected Mendelian frequency and had a
normal lifespan to at least 9 months of age, similar to their con-
trol littermates (Gulo KO—Gulo tm1mae/tm1mae;Slc2a10 +/+, Slc2a10
KO—Gulo +/+;Slc2a10 −/− and WT—Gulo +/+;Slc2a10 +/+). DKO
mice developed normally and showed no obvious gross anoma-
lies, skeletal dysmorphisms or skin abnormalities. However, the
weight of female DKO mice was slightly reduced, at each mea-
surement time point (Supplementary Material, Fig. S2).
Slc2a10;Gulo DKO mice do not completely copy the
human ATS phenotype
We carried out serial ultrasound measurements at multiple
locations in the cardiovascular system of 10 male and 10 female
mice of each selected genotype (DKO, Slc2a10 KO,Gulo KO,WT) at
6 weeks and 3, 6 and 9 months of age. Diameters of the ascend-
ing aorta, distal ascending aorta, aortic arch and descending
aorta showed a subtle but statistically significant decrease in
DKO mice compared to their WT littermates, for a given age
and sex (Fig. 2). More distal measurements (carotid arteries) did
not reveal any significant diameter alterations (Supplementary
Material, Fig. S3). Fractional shortening and ejection fraction
were comparable between the selected genotypes at 6weeks and
3 months of age (Supplementary Material, Fig. S4). We did not
detect aortic or mitral valve insufficiency using pulsed Doppler.
Detailed microscopic analysis of the aortic tree, eye arterioles
and the circle of Willis, obtained from polymer replicas of the
cardiovascular system at 9 months of age, did not indicate any
omnipresent structural anomalies such as tortuosity, abnormal
implantation of the aortic side branches or aneurysms.However,
one out of three analyzed female DKO mice had a local stenosis
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Figure 1. Slc2a10 expression levels in skin and aortic tissue. RT-qPCR analysis identifies a near absence of Slc2a10WTmRNA inmice homozygous for Slc2a10mutations
(Slc2a10 KO and DKO), compared to mice harboring the Slc2a10WT allele (Gulo KO and WT). Displayed average values represent the relative expression data in the skin
or aorta for three male and three female mice. Error bars represent the SD, ∗P≤ 0.05; ∗∗P≤0.01; ∗∗∗P≤ 0.001.
in the vertebral artery (Fig. 3; Supplementary Material, Fig. S5).
At 9 months, elastic fiber staining of aortic tissue showed mild
age-related changes, such as sporadic elastic fiber fragmentation
or accumulation, in the tunica media of the aortic wall across all
selected genotypes.
Picrosirius red (PR) polarization staining on the skin tissue
showed no major alterations in collagen deposition, but patches
of increased collagen deposition could be discerned in female
DKO mice (Fig. 4; Supplementary Material, Fig. S6).
Transmission electron microscopy (TEM) analysis of female
skin samples showed a normal elastic fiber architecture (Sup-
plementary Material, Fig. S7). Collagen fibril diameters were
significantly reduced in DKO compared to WT mice (Fig. 5).
In vitro analysis of Slc2a10;Gulo DKO vascular smooth
muscle cells shows decreased ECM deposition
We examined the ECM deposition in vascular smooth muscle
cells (VSMCs) of the DKO and WT genotypes (Fig. 6). In contrast
to WT VSMCs, DKO VSMCs did not show a base network of rec-
ognizable and organized fibronectin fibers stretching between
the cells but presented with a reduced intensity of fibronectin
staining with a more fuzzy appearance (Fig. 6A; Supplementary
Material, Fig. S8). A similar observation was made for fibrillin-
1 where stained fibers appeared thinner in DKO VSMCs (Fig. 6B;
Supplementary Material, Fig. S8).WT VSMCs showed clear stain-
ing of tropoelastin that appeared in a fibrillar structure (Fig. 6C),
next to the presence of a strong fiber network of both fibulin-4
(Fig. 6D) and fibulin-5 (Fig. 6E). In DKO VSMCs, a reduced staining
of fibulin-4 and fibulin-5 (Fig. 6D and E; SupplementaryMaterial,
Fig. S8) and an overlapping network of tropoelastin and fibulins
(Fig. 6C; Supplementary Material, Fig. S8) could be observed. We
further assessed LTBP-4, which was present in clear fibrillar
structures (Fig. 6F) in both WT and DKO VSMCs but appeared
less intense in DKO VSMCs, organized in a more densely packed
fibril network (Fig. 6F; Supplementary Material, Fig. S8). Taken
together, these data show that DKO VSMCs displayed decreased
deposition of the various components of the ECM compared to
WT VSMCs.
Slc2a10;Gulo DKO VSMCs do not show altered activation
of canonical TGFβ signaling
We investigated canonical TGFβ signaling activation in VSMCs
derived fromWT andDKOmouse aortas.Under an unstimulated
serum-deprived condition, DKO VSMCs showed similar levels of
Smad2 phosphorylation compared to WT VSMCs (Fig. 7A and B).
Following TGFβ stimulation, both WT and DKO VSMCs demon-
strated a strong and comparable increase in phosphorylation of
Smad2 after 15 min (Fig. 7A). Quantification of phosphorylated
Smad2 to total Smad2 ratio revealed a further increase to its
maximum at 60 min of stimulation after which it decreased
(Fig. 7A and B). In conclusion, our data do not support aberra-
tions in the activation of the canonical TGFβ signaling pathway
in DKO VSMCs compared to control VSMCs.
Slc2a10;Gulo DKO VSMCs show a reduced maximum
oxygen consumption rate
Since GLUT10 impairment has previously been associated with
mitochondrial dysfunction in a Glut10 mouse model with
missense mutations (24) and a slc2a10 zebrafish knockdown
model (21), we analyzed the oxygen consumption rate (OCR) of
DKO compared to WT VSMCs as a marker for mitochondrial
function (Fig. 8A). Phase I represents the basal and unstimulated
OCR.Addition of oligomycin in phase II inhibits theATP synthase
and reduces the OCR. In phase III, treatment with fluoro-
carbonyl cyanide phenylhydrazone (FCCP) uncouples oxygen
consumption from ATP production and raises OCR to its
maximum.Addition of antimycin A in phase IV inhibits complex
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Figure 2. Serial ultrasound measurements obtained in WT, Gulo KO, Slc2a10 KO and DKO mice at 6 weeks and 3, 6 and 9 months of age. Shown data were acquired
at the level of the aortic root, proximal ascending aorta, distal ascending aorta and aortic arch. Left and right column images represent data obtained in male (M)
and female (F) animals, respectively. Shown P-values were obtained using a linear mixed model with covariance pattern modeling, without interactions. As a result,
P-values should be interpreted when making the comparison for a given age and sex. Error bars represent 95% confidence intervals. ∗P≤ 0.05; ∗∗P≤0.01.
III of the mitochondria and blocks mitochondrial respiration.
Figure 8B and C contains the quantification of the mean value
of phases I and III per genotype. Basal OCR did not differ between
both genotypes (Fig. 8A and B). However, when VSMCs were
treated with FCCP to reach maximum respiration, DKO VSMCs
displayed decreased maximum respiration rates compared to
WT VSMCs (Fig. 8A and C).
Discussion
Arterial tortuosity may occur in both innate and acquired vascu-
lopathies, such as persistent hypertension and neoangiogenesis,
and may associate with an increased vascular risk, including
aneurysm formation and blood vessel rupture. Monogenic
conditions may be helpful in delineating the underlying
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Figure 3. Vascular corrosion casts of WT, Gulo KO, Slc2a10 KO and DKO female mice. Representative images of the aortic arch and its side branches, the circle of Willis
and the eye arterioles are shown. A local narrowing in the vertebral artery in the circle of Willis could be observed in one DKO mouse (white-framed enlargement).
Scale bars: 2 mm.
pathophysiology of altered vascular patterning. In this study, we
developed and characterized a novel mousemodel for ATS, since
the previously reportedmousemodels for ATS failed to recapitu-
late themajor hallmarks of the humandisease (22,23).Ourmodel
addressed two concerns regarding the previous models. Firstly,
we developed an Slc2a10 knock-out, which abolishes GLUT10
functionwhile the previously reportedmissensemutationswere
only predicted to be pathogenic (22,23). Secondly, we impaired
AA synthesis in our model by disrupting the Gulo gene, aiming
to mimic the physiological conditions in human more reliably.
Indeed,Gulo encodes L-gulonolactone oxidase, an ERmembrane-
bound enzyme that catalyzes the last step in the vitamin C
biosynthesis pathway (26). It became mutated in many species,
such as teleost fishes, guinea pigs and anthropoid primates,
including humans, making these species unable to synthesize
vitamin C and rely on its dietary uptake (27). Vitamin C plays an
essential role as an antioxidant and in collagen synthesis. Since
recent evidence indicates that GLUT10 function may include
transport of DHA into subcellular compartments (14,17,24), it
could be hypothesized that murine developmental processes
do not suffer from Slc2a10 mutations and localized vitamin C
hypovitaminosis, which would explain the absence of a relevant
phenotype in Slc2a10 mutant mice (16,23).
Nevertheless, in this study, we only observed mild cardiovas-
cular manifestations in the DKO ATS mouse model. Ultrasound-
guided characterization revealed a subtle stenosis from the prox-
imal ascending aorta to the descending aorta in DKO mice but
only statistically significant when compared with their WT lit-
termates. Moreover, the reduced weight in the DKOmice further
questions the biological relevance of these results.
Histopathology of ATS patient vascular tissue invariably
shows substantial fragmentation of the elastic laminae in
the tunica media (1), while conversely the previously described
Glut10G128E mouse model mainly presented with increased
arterial wall thickness, most prominent at the age of 15 months
(22,24). Our model only reveals mild elastic fiber anomalies in
all genotypes that are likely age-related changes. Nevertheless,
dermal collagen histology revealed patches of increased collagen
deposition in female DKO mice, which has also been observed
in skin tissue of ATS patients (1) and might contribute to their
‘doughy’ skin characteristics. Ultrastructural analysis of skin
tissue of DKOmice additionally revealed collagen fiber diameter
alterations in DKO mice, but did not reveal major defective
elastin deposition, which contrasts with TEM observations in
ATS patients (1).
The observed mild phenotypic abnormalities seem to be
more pronounced in female mice, suggesting a sex discrepancy,
even for nulliparous mice. Influences of sex in connective tis-
sue homeostasis and disease have been previously recognized.
However, most studies indicate that male mouse models for
connective tissue disorders show more severe phenotypes than
female mice (28–31), which contrasts with our study.
Despite the absence of a major clinical or histological phe-
notype, we did identify defective ECM deposition in cultured
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Figure 4. Histological analysis of WT, Gulo KO, Slc2a10 KO and DKO female mice. Picrosirius red (PR) polarization staining (upper row) for collagen reveals the presence
of patches with accumulated collagen deposition (white arrowheads) in the skin of DKOmice. Verhoeff-Van Gieson (VVG) elastic fiber staining (middle row) showsmild
elastic fiber anomalies in the aortic wall of all studied mice (black arrowheads).
Figure 5. Electron microscopic quantification of collagen diameters in WT and DKO skin samples. DKO mice show decreased collagen fiber diameters, compared to
WT mice (measurements on EM micrographs of two animals per genotype). TS: transverse section, LtS: longitudinal section. Scale bar upper row: 1.0 μm, lower row:
0.3 μm. Error bars represent 95% confidence intervals. ∗∗∗P≤ 0.001.
VSMCs of DKO mice. AA is a cofactor for cross-linking enzymes
such as lysyl oxidase and lysyl oxidase-like enzymes. Hence, it is
not surprising that elastin and collagen assembly are primarily
affected. Nevertheless, our observations also indicate reduced
deposition of the early-stage fibril-forming networks includ-
ing the fibronectin and fibrillin-1 microfibrillar scaffolds. This
reflects an earlier observation that in the absence of AA, not
only deposition of collagen but also of fibronectin is greatly
reduced (32). Indeed, collagen I fibers interact preferentially
with relaxed (but in a lesser extent to stretched) fibronectin
fibers (32), and collagen 1 increases fibronectin deposition (33).
Therefore, ECM assembly cannot be seen as a consequential
process but rather as an interactive and growing mechano-
sensing network of components. Similarly, fibulin-4 and fibulin-
5 deposition was clearly reduced, while LTBP4 deposition was
only slightly affected. Though further experimentation is nec-
essary, we hypothesize that latent TGFβ-binding proteins might
be upregulated due to their primary role in elastogenesis (34).
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Figure 6. Immunofluorescence staining for fibronectin (A), fibulin-1 (B), tropo-elastin (C), fibulin-4 (D), fibulin-5 (E) and LTPB-4 (F) shows deposition of the ECM
components after 7 days of culture. DKO VSMCs show less distinct ECM structures compared to WT VSMCs. Scale bars represent 100 μm.
Our results are in line with findings by Zoppi et al. (12), who pre-
viously showed ECM disarray in skin fibroblasts of ATS patients.
In addition, a recent study revealed an abnormal microfibrillar
scaffold and incomplete elastic core assembly in skin samples
of ATS patients (1) that likely reflect defective ECM assembly
at multiple levels, as shown in our model. Since defective ECM
assembly is often associated with vascular phenotypes (35,36),
thismight indicate thatmicemay rely on othermechanisms that
overcome the deleterious defects of abnormal ECM assembly.
In several aneurysm syndromes, dysregulation of the canon-
ical TGFβ signaling pathway is at play in aneurysm formation
(37,38). However, while we observed ECM abnormalities, DKO
VSMCs do not show altered phosphorylation of Smad2 upon
TGFβ stimulation over time as well as under basal, unstimu-
lated, conditions. An initial report indicated a prolonged signal
increase for downstream readouts of TGFβ signaling in arterial
tissue of one ATS patient (3). This finding remained unconfirmed
on both fibroblast cultures (12) and skin or artery tissue (1) in
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Figure 7. DKO VSMCs do not show altered activation of the canonical TGFβ signaling pathway. DKO VSMCs do not show increased phosphorylation of Smad2 without
TGFβ stimulation and do not differ from WT VSMCs in basal conditions. Stimulation with TGFβ led to increased phosphorylation of Smad2 in both WT and DKO
VSMCs. There was no difference in pSmad2/Smad2 ratio between the two genotypes. The data show two independent cell lines from two experiments. The data points
represent average values of an independent cell line per experiment. Results are depicted as mean±SD.
an extended number of patients. A role for noncanonical αvβ3
integrin-mediated TGFβ signaling in the ATS pathomechanisms
has been suggested (12). Our results add to the uncertainty
regarding the role of TGFβ signaling in the pathomechanisms
underlying many elastic fiber diseases, but cannot account for
a possible contribution of spatiotemporal regulation of TGFβ
signaling.
A number of studies have pointed towards a key role for
oxidative stress in ATS pathogenesis. For instance, GLUT10 has
been identified as a mitochondrial DHA transporter, and it was
shown that increased mitochondrial targeting of GLUT10 and
associated increased mitochondrial DHA uptake was triggered
by stress and aging conditions (14,24). In a morpholino slc2a10
knockdown zebrafish model, altered OCR and differential gene
expression analysis showed involvement in oxidative signaling
(21). In the Glut10G128E mousemodel, Syu et al. (24) similarly iden-
tified a decreased maximum OCR in early passage Glut10G128E
VSMCs. In this study, we compared basal and maximal OCR in
VSMCs of DKO and control mice and identified a normal basal
OCR in DKO VSMCs. However, following treatment with FCCP,
a decreased maximum OCR could be observed in DKO VSMCs,
compared to WT. Since basal OCR was comparable in DKO and
WT VSMCs, the need for a stressor to dysregulate mitochondrial
function in DKO VSMCs could explain the reduced maximum
OCR after FCCP treatment. However, it has been suggested
that an aberrant maximal OCR only corresponds to the initial
symptoms of mitochondrial dysfunction caused by SLC2A10
mutations, due to reactive oxygen species (ROS) that trigger
arterial wall remodeling. In its turn, this leads to additional ROS
production, and disease progression promotes further decline in
mitochondrial function. It is also plausible that mitochondrial
dysfunction is a more ubiquitous phenomenon associated
with aneurysmal disease. Van der Pluijm et al. investigated
mitochondrial function in fibulin-4R/R and Tgfbr-1M318R/+ mouse
VSMCs and found decreased mitochondrial respiration in these
mouse models. In addition, skin fibroblasts of aneurysmal
patients with FBN1, TGFBR2 or SMAD3 mutations revealed
mitochondrial dysfunction as well (25).
Finally, due to themild nature and low abundance of relevant
phenotypic alterations, it could be argued that this novel ATS
DKO mouse model does not appear to be a suitable disease
model to study the pathomechanisms underlying ATS (22,23).
While the lack of a severe phenotype could be attributed to the
genetic background of the used mouse strains, possibly hinder-
ing phenotypic penetrance (39), the underlying cause could also
be biological robustness. This is a phenomenon by which the
functionality of the mutated gene is maintained by increased
expression of related genes (40,41), as was demonstrated ear-
lier in a number of other mouse disease models (42,43). One
mechanism of biological robustness is transcriptional adapta-
tion (44,45). This mechanism is triggered by mRNA degradation
products and is believed to act via sequence similarity (46,47).
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Figure 8. DKO VSMCs show a reduced maximum OCR. In basal conditions, DKO and WT VSMCs do not differ in OCR, while treatment with FCCP results in a decreased
maximum OCR of DKO VSMCs. Data represents two independent cell lines per genotype measured in three technical replicates. The data points represent average
values of an independent cell line per experiment. Results are depicted as mean±SD. ∗∗P≤ 0.01.
Since Slc2a10 is a member of a large family of facilitative glucose
transporter proteins harboring a high sequence similarity, this
mechanism is plausible (48). It could also be argued that an
extensive dose (60 mg/kg body weight) of ascorbic may have
masked the development of a relevant phenotype, since this
dose exceeds the daily recommended dose in human (1 mg/kg
body weight) extensively. However, species differences might
complicate the direct comparison or extrapolation of the opti-
mal daily dose between mouse and human. A daily AA dose
of 1 mg/kg body weight corresponds in human to plasma AA
levels of 25 μm. To reach comparable levels in mouse plasma,
a significantly higher dose (80 mg/kg body weight) needs to be
administered (49).
Nevertheless, the current DKO mouse model could be of
importance in revealing redundant gene networks, alternative
pathways or modifier genes, possibly providing clues for future
therapies. Moreover, since isolated VSMCs of DKO mice mim-
icked cellular disturbances found in cell cultures of ATS patients,
these VSMCs could potentially be used for further identification
of the molecular mechanisms that underlie ATS, while analyses
at the histological level may reveal adaptive mechanisms that
contribute to the phenotypic rescue.
In conclusion, we developed a novel mouse model for ATS,
DKO for Gulo and Slc2a10. While our model does not phenocopy
humanATS, it did reveal alterations at the cellular level including
disturbed ECM assembly and altered cellular respiration. Our
model confirms a role for ascorbate synthesis and compartmen-
talization in the disease mechanisms leading to ATS andmay be
helpful to identify the mechanisms underlying the phenotypic
rescue in mice.
Materials and Methods
Animals
Heterozygous knock-out mice for Slc2a10, in which a selec-
tion cassette replaces a sequence ranging from exon 2 to the
beginning of exon 5, were purchased from Taconic Biosciences
(Germantown, New York, USA, cat. nr. TF2438) (Supplementary
Material, Fig. S1A). The mutation resides in a mixed 129/SvEv-
C57BL/6 genetic background. Heterozygous knock-out mice for
Gulo, in which a selection cassette replaces exons 3 and 4, were
purchased from MMRRC (RRID MMRRC_000015-UCD) (Supple-
mentary Material, Fig. S1A). This mouse line, residing in a mixed
129/SvEv-C57BL/6 genetic background as well, was previously
described byMaeda et al. (49). The two lines were crossed accord-
ing to a breeding scheme depicted in Supplementary Mate-
rial, Fig. S1B. To allow for valid data generation and to take
into account any potential influence of genetic background,
all comparisons were made between littermates from the F2
generation. Male and female mice of the following genotypes
were studied: double knock-out (DKO—Gulo tm1mae/tm1mae;Slc2a10
−/−), single knock-out (Gulo KO—Gulo tm1mae/tm1mae;Slc2a10 +/+
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and Slc2a10 KO—Gulo +/+;Slc2a10 −/−) and wild type (WT—Gulo
+/+;Slc2a10 +/+). All procedures were conducted in compliance
with the European Parliament Directive 2010/63/EU and with the
approval of the Ghent University ethical committee on animal
experiments (Permit Number: ECD 13/17). All animals were fed
ad libitum with a standard mouse breeding feed, supplemented
with 300 mg/kg AA (ssniff® Spezialdiäten). The administered
AA dose is based on an average food intake of 4 g/day, for a
mouse with an average weight of 20 g. This dose translates to a
daily dose of 60 mg/kg body weight, which is comparable to the
average administered AA dose of the first report on this model
(110 mg/kg), by Maeda et al. (49). Mice were maintained in a fully
controlled animal facility (12:12 h light/dark cycle at ±22◦C).
Genotyping
Seven-day-old mice were toe-clipped, after which genomic DNA
was prepared from the tissue using the KAPA Express Extract
DNA Extraction Kit (Sigma-Aldrich, St. Louis, Missouri, USA,
cat. nr. KK7103). For both Gulo and Slc2a10, the DNA was PCR-
amplified using specific primers detecting the WT and mutant
alleles. The genotype was determined based on PCR product
presence and band size (Supplementary Material, Table S1).
Quantitative real-time PCR
Skin and aortic tissues from three male and three female mice
of each selected genotype were harvested at the age of 9 months
and submerged in RNAlaterTM Stabilization Solution (Thermo
Fisher Scientific,Waltham,Massachusetts, USA, cat. nr. AM7020)
prior to the RNA extraction procedure, carried out with the
RNeasy® Mini kit (Qiagen, Hilden, Germany, cat. nr. 74106). Next,
cDNA synthesis was performed using the iScript cDNA synthesis
kit (Bio-Rad, Hercules, Californa, USA, cat. nr. 1708891). RT-qPCR
reactions were carried out in quadruple on an LC480 machine
(Roche, Basel, Switzerland). The reaction mix consisted of cDNA,
LightCycler® 1536 DNA ProbesMaster (Roche, Basel, Switzerland,
cat. nr. 05502381001), LightCycler® 480 High Resolution Melting
Dye (Roche, Basel, Switzerland, cat. nr. 04909640001) and specific
primers amplifying the Slc2a10 transcript or expressed repeat
elements (Supplementary Material, Table S2) (50), to which all
reactions were normalized. Data analysis was carried out with
qBase+ (Biogazelle). Values plotted correspond to the means
of three male and three female biological replicates. Error bars
shown represent 95% confidence intervals. Data were analyzed
usingWelch’s ANOVA, followed by a Games-Howell post hoc test.
In vivo imaging
Serial ultrasound imaging was performed using a dedicated
ultrasound apparatus (Vevo 2100, FUJIFILM VisualSonics,
Toronto, Canada), equipped with a high-frequency linear array
transducer (MS 550D, frequency 22–55MHz). Imagingwas carried
out on mice of 6 weeks and 3, 6 and 9 months old. Ten male and
10 femalemice of the selected genotypes were studied. Themice
were anesthetized with 1.5% isoflurane mixed with 0.5 l/min
100% O2. Body temperature was maintained at 37◦C, by placing
the mice on a heating pad. Artery and cardiac measurements
were carried out in concordance with previously established
guidelines (51). In short, the diameter measurements of the
aorta at the level of the aortic root, proximal ascending aorta,
distal ascending aorta, aortic arch and descending aorta were
performed, next to diameter measurements of the carotid
arteries and cardiac assessment. Three cardiac cycles for each
animal were analyzed (VevoLAB 1.7.0, FUJIFILM VisualSonics,
Toronto, Canada). For each measurement location, a linear
mixed model with covariance pattern modeling was fitted to
account for correlated responses (diameters) within the same
subject. Genotype, age and sex were considered as categorical
explanatory variables. Starting from a saturated mean model
with unstructured covariance matrix and using residual maxi-
mum likelihood (REML), the covariance model was simplified
by comparison with simpler structures through Akaike’s
information criterion. The following covariance matrices that
were as parsimonious as possible were selected: unstructured
(aortic root), autoregressive (proximal ascending aorta), Toeplitz
(distal ascending aorta) and compound symmetry (all other
measurement locations). Afterwards, the fixed part of themodel
was simplified by testing simpler models using maximum
likelihood. All final models included the main effects of
genotype, age and sex without interaction terms and were
refitted with REML. Values plotted correspond to the means
of ±10 biological replicates. Error bars shown represent 95%
confidence intervals.
Vascular corrosion casting
The vascular corrosion casting technique, based on the injection
of a polymer to capture the 3D structure of the vasculature,
was performed on three male and three female mice of each
selected genotype at the age of 9months as previously described
(23). Briefly, 2–3 ml Batson’s solution (Polysciences, Batson’s #17
corrosion kit) was retrogradely injected in the abdominal aorta
through a 26G catheter. After completion of the polymeriza-
tion reaction, mouse bodies were macerated overnight in a 25%
KOH solution. The resulting casts were cleaned, evaluated and
photographed using a dissecting microscope, equipped with a 5
megapixel camera (Leica, Wetzlar, Germany).
Histology
From the three male and three female mice of each selected
genotype, skin and aorta (9-month-old animals) were collected
for histological analysis. Samples were formalin-fixed and
paraffin-embedded, after which 5-μm-thick paraffin sections
were made. Sections were subjected to the standard Verhoeff-
Van Gieson and PR histological staining procedures, prior to
visualization on a Zeiss Axio Observer Z1 microscope.
Transmission electron microscopy
Sample fixation was carried out in a 4% formaldehyde (EM
grade), 2.5% glutaraldehyde (EM grade) and 0.1 M cacodylate
buffer solution. Samples were placed in a vacuum oven for
30 min and left rotating for 3 h at room temperature. This
solutionwas later replacedwith fresh fixative, and sampleswere
left rotating over night at 4◦C. After washing, samples were post-
fixed in 1% OsO4 with K3Fe(CN)6 in 0.1 M Na-cacodylate buffer,
pH 7.2. After washing in double-distilled H2O, samples were sub-
sequently dehydrated through a graded ethanol series, including
bulk staining with 2% uranyl acetate at the 50% ethanol step, fol-
lowed by embedding in Spurr’s resin.To select the area of interest
on the block and in order to have an overview of the phenotype,
semi-thin sections were first cut at 0.5 μm and stained with
toluidine blue. Ultrathin sections of a gold interference color
were cut using an ultramicrotome (Leica EM UC6), followed by
post-staining in a Leica EM AC20 for 40 min in uranyl acetate
at 20◦C and for 10 min in lead stain at 20◦C. Sections were
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collected on formvar-coated copper slot grids. Grids were viewed
with a JEM 1400plus transmission electron microscope (JEOL,
Tokyo, Japan) operating at 80 kV. Collagen diameter measure-
ments were carried out with Fiji (52). Error bars shown represent
95% confidence intervals. Data were analyzed with a two-tailed
t-test.
VSMC isolation and cell culture
Mice (at an age of 25 days) were euthanized (CO2) and autopsied
according to standard protocols. Primary VSMCs from the tho-
racic aorta were isolated according to the collagenase digestion
method of Proudfoot and Shanahan (53). Each cell line was
derived from a single aorta. Primary VSMCs were cultured on
gelatinized dishes in SmBM medium supplemented with the
SmGM-2 kit (Lonza, Basel, Switzerland, cat. nr. CC-3182). Unless
otherwise specified, two cell lines per genotype were assessed.
Immunofluorescence of ECM
ECMprotein production byVSMCswas determined by immunoflu-
orescence. VSMCs were seeded at 50 000 cells/well in eight-
well removable chamber slides and grown for 7 days to allow
ECM deposition. VSMCs were fixed with an ice-cold 70:30
methanol/acetone mixture for 5 min and washed with PBS.
Coverslips were blocked for 1 h with PBS supplemented with
10% normal goat serum (Agilent, Santa Clara, California, USA,
cat. nr. X0907). Primary antibodies (Supplementary Material,
Table S3) were incubated overnight at 4◦C in PBS. Coverslips were
washed three times with PBS for 5 min each prior to incubation
with the secondary antibody for 1.5 h at room temperature
(Molecular Probes, anti-rabbit Alexa Fluor 594, 1:1000). Coverslips
were washed and mounted to glass slides with Vectashield
supplemented with DAPI (Vector Laboratories, Peterborough,
UK, cat. nr. H-1200) and sealed with nail polish. Images were
recorded on awide-field epifluorescentmicroscope (Axio Imager
D2, Zeiss). Quantification of the immunofluorescent signal was
performed by calculating the corrected total cell fluorescence
(CTCF) of the ECM components corrected for the number of
nuclei. The CTCF was determined by setting a color threshold
to select the fibers in the image with Fiji image-analyzing
software (52) and determining the integrated density of this
area (intensity of the fluorescence). This measurement was
corrected for the background fluorescence and the total area of
the fibers and results in the CTCF. The CTCF was then divided by
the number of nuclei that were present in the measured image.
Data were corrected for outliers with the Grubbs’ test for outliers
(54). Statistical analysis was performed with a nonparametric
Mann–Whitney test. Significance was tested two-tailed. Results
are expressed as mean±SD.
TGFβ stimulation
VSMCs were seeded in six-well plates to reach confluence and
were allowed to attach for 24 h. The following day, medium
was changed to SmGM-2 medium without fetal calf serum,
and VSMCs were serum deprived for 24 h prior to TGFβ stim-
ulation. Protein samples were collected after 0 min, 15 min,
30 min, 1 h and 4 h of stimulation with TGFβ1 (BioVision,
Milpitas, California, USA, cat. nr. 4342-5). Cells were scraped
in PBS supplemented with protease inhibitor cocktail (Roche,
Basel, Switzerland, cat. nr. 11836145001, 1:100) and phosphatase
inhibitor cocktail (Sigma-Aldrich, St. Louis,Missouri, USA, cat. nr.
P0044, 1:100) and lysed in an equal volume of 2× Laemmli buffer
(4% SDS, 20% glycerol, 120 mm Tris pH 6.8) supplemented with
protease inhibitor cocktail and phosphatase inhibitor. Lysates
were first cleared from large DNA by passing through a 25G
needle and then heated to 65◦C for 10 min. Protein concentra-
tions were measured with the Lowry protein assay as previously
described (55). Equal amounts of protein were separated for
size by SDS-PAGE and then transferred to a PVDF membrane
(1 h, 100 V, Immobilon) and blocked with either 3% milk in PBS
supplemented with 0.1% Tween-20 (1 h, room temperature). The
primary antibodywas incubated for 45min at room temperature
or overnight at 4◦C for phosphorylated Smad2 (see Supplemen-
tary Material, Table S3 for primary antibodies). The membranes
were washed five times with 0.1% Tween-20 in PBS and then
incubated with horseradish peroxidase-conjugated secondary
antibodies (Jackson ImmunoResearch, Ely, UK, 1:2000) for 1 h at
room temperature. Bound secondary antibodies were detected
with an Amersham Imager 600 (GE Healthcare Life Sciences,
Chicago, Illinois, USA) using chemiluminescence. Band intensity
was quantified using Fiji image-analyzing software (52). Data
were corrected for outliers with the Grubbs’ test for outliers
(54). Statistical analysis was performed with a nonparametric
Mann–Whitney test. Significance was tested two-tailed. Results
are expressed as mean±SD.
Mitochondrial respiration
OCR was measured using an XF-24 Extracellular Flux Analyzer
(Seahorse, Agilent, Santa Clara, California, USA). Respiration was
measured in XF assay media (non-buffered DMEM), in basal
conditions and in response to 1 μm oligomycin (ATP synthase
inhibitor), 1 μm FCCP(uncoupler) and 1 μm antimycin A (complex
III inhibitor). Smooth muscle cells were seeded at a density of
30 000 cells/well and analyzed after 24 h. Optimal cell densi-
ties were determined experimentally to ensure a proportional
response to FCCP with cell number. For these experiments 6–8
wells were measured per time point (56,57). Data were corrected
for outliers with the Grubbs’ test for outliers (54). Statistical
analysis was performed with a nonparametric Mann–Whitney
test. Significance was tested two-tailed. Results are expressed
as mean±SD.
Supplementary Material
Supplementary Material is available at HMG online.
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